Efficacy and safety comparison of DL-3-n-butylphthalide and cerebrolysin: Effects on neurological and behavioral outcomes in acute ischemic stroke

Experimental and Therapeutic Medicine

Volumn 11, Issue 5, 2016, Pages 2015-2020

  Xue, Li Xia ^a   Zhang, Ting ^a   Zhao, Yu Wu ^a   Geng, Zhi ^a   Chen, Jing Jiong ^a   Chen, Hao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Acute ischemic stroke; Cerebrolysin; DL 3 n butylphthalide

Indexed keywords

ACETYLSALICYLIC ACID; BUTYLPHTHALIDE; CEREBROLYSIN; PLACEBO;

AGED; ARTICLE; BARTHEL INDEX; BEHAVIOR; BLOOD PRESSURE MONITORING; BRAIN ISCHEMIA; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART RATE; HUMAN; MALE; MORTALITY RATE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROMONITORING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OXYGEN CONCENTRATION; SCORING SYSTEM;

EID: 84961784039     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2016.3139     Document Type: Article

References (24)

1. Chang Q and Wang XL: Effects of chiral 3-n-butylphthalide on apoptosis induced by transient focal cerebral ischemia in rats. Acta Pharmacol Sin 24: 796-804, 2003.
2. Liu CL, Liao SJ, Zeng JS, Lin JW, Li CX, Xie LC, Shi XG and Huang RX: dl-3n-butylphthalide prevents stroke via improvement of cerebral microvessels in RHRSP. J Neurol Sci 260: 106-113, 2007.
3. Liao SJ, Lin JW, Pei Z, Liu CL, Zeng JS and Huang RX: Enhanced angiogenesis with dl-3n-butylphthalide treatment after focal cerebral ischemia in RHRSP. Brain Res 1289: 69-78, 2009.
4. Xu J, Wang Y, Li N, Xu L, Yang H and Yang Z: L-3-n-butylphthalide improves cognitive deficits in rats with chronic cerebral ischemia. Neuropharmacology 62: 2424-2429, 2012.
5. Zhang L, Yu WH, Wang YX, Wang C, Zhao F, Qi W, Chan WM, Huang Y, Wai MS, Dong J and Yew DT: DL-3-n-Butylphthalide, an anti-oxidant agent, prevents neurological deficits and cerebral injury following stroke per functional analysis, magnetic resonance imaging and histological assessment. Curr Neurovasc Res 9: 167-175, 2012.
6. Ren J, Sietsma D, Qiu S, Moessler H and Finklestein SP: Cerebrolysin enhances functional recovery following focal cerebral infarction in rats. Restor Neurol Neurosci 25: 25-31, 2007.
7. Zhang C, Chopp M, Cui Y, Wang L, Zhang R, Zhang L, Lu M, Szalad A, Doppler E, Hitzl M and Zhang ZG: Cerebrolysin enhances neurogenesis in the ischemic brain and improves functional outcome after stroke. J Neurosci Res 88: 3275-3281, 2010.
8. Sharma HS, Sharma A, Mössler H and Muresanu DF: Neuroprotective effects of cerebrolysin, a combination of different active fragments of neurotrophic factors and peptides on the whole body hyperthermia-induced neurotoxicity: Modulatory roles of co-morbidity factors and nanoparticle intoxication. Int Rev Neurobiol 102: 249-276, 2012.
9. Sharma HS, Menon PK, Lafuente JV, Aguilar ZP, Wang YA, Muresanu DF, Mössler H, Patnaik R and Sharma A: The role of functionalized magnetic iron oxide nanoparticles in the central nervous system injury and repair: New potentials for neuroprotection with Cerebrolysin therapy. J Nanosci Nanotechnol 14: 577-595, 2014.
10. Cui LY, Zhu YC, Gao S, Wang JM, Peng B, Ni J, Zhou LX, He J and Ma XQ: Ninety-day administration of dl-3-n-butylphthalide for acute ischemic stroke: A randomized, double-blind trial. Chin Med J (Engl) 126: 3405-3410, 2013.
11. Hong Z, Moessler H, Bornstein N, Brainin M and Heiss WD; CASTA-Investigators: A double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of Cerebrolysin in patients with acute ischaemic stroke in Asia - CASTA. Int J Stroke 4: 406-412, 2009.
12. Heiss WD, Brainin M, Bornstein NM, Tuomilehto J and Hong Z; Cerebrolysin Acute Stroke Treatment in Asia (CASTA) Investigators: Cerebrolysin in patients with acute ischemic stroke in Asia: Results of a double-blind, placebo-controlled randomized trial. Stroke 43: 630-636, 2012.
13. Lang W, Stadler CH, Poljakovic Z and Fleet D; Lyse Study Group: A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke. Int J Stroke 8: 95-104, 2013.
14. Cerebrovascular Disease Working Groups, Chinese Academy of Neurology: Guidelines for the management of ischemic stroke (China 2010). Zhonghua Shen Jing Ke Za Zhi 43: 146-153, 2010 (In Chinese).
15. Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, Haley EC, Grotta J and Marler J: Improved reliability of the NIH stroke scale using video training. NINDS TPA stroke study group. Stroke 25: 2220-2226, 1994.
16. Sulter G, Steen C and De Keyser J: Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 30: 1538-1541, 1999.
17. Guy W: ECDEU assessment manual for psychopharmacology (revised). U.S. Department of Health, Education, and Human Welfare Publication No. (ADM) 76-338 Rockville, MD, 341-345, 1976.
18. Liu L, Wang D, Wong KS, Wang Y: Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke 42: 3651-3654, 2011.
19. Liu M, Wu B, Wang WZ, Lee LM, Zhang SH and Kong LZ: Stroke in China: Epidemiology, prevention and management strategies. Lancet Neurol 6: 456-464, 2007.
20. Tymianski M: Novel approaches to neuroprotection trials in acute ischemic stroke. Stroke 44: 2942-2950, 2013.
21. Xiong J, Feng YP: The protective effect of butylphthalide against mitochondrial injury during cerebral ischemia. Acta Pharmaceutica Sinica 35: 408 412, 2000.
22. Zhang T, Jia W and Sun X: 3-n-Butylphthalide (NBP) reduces apoptosis and enhances vascular endothelial growth factor (VEGF) up-regulation in diabetic rats. Neurol Res 32: 390-396, 2010.
23. Zhang T, Yan W, Li Q, Fu J, Liu K, Jia W, Sun X and Liu X: 3-n-Butylphthalide (NBP) attenuated neuronal autophagy and amyloid-β expression in diabetic mice subjected to brain ischemia. Neurol Res 33: 396-404, 2011.
24. Wang HM, Zhang T, Huang JK and Sun XJ: 3-N-butylphthalide (NBP) attenuates the amyloid-β-induced inflammatory responses in cultured astrocytes via the nuclear factor-κB signaling pathway. Cell Physiol Biochem 32: 235-242, 2013.